Fred Beyerlein Email & Phone Number

United States

Fred provides consulting services to the Life Science, Molecular Diagnostic, and Medical Device marketplace. Drawing on his extensive experience in early stage enterprise development, early and mid-stage product and market strategy, financial systems and overall business strategy, he provides his clients with workable solutions to support their successful.

Tampa, Florida

NeuX Technologies is an early commercial stage company specializing innovative health, fitness and wellness applications with revolutionary solutions that successfully address life changing conditions, including chronic pain and neuromuscular dysfunction, and dramatically improves human performance. NeuX’s pioneering technologies are non-pharmaceutical.

Greater Boston Area

Axios Biosciences is revolutionizing oncology drug discovery by identifying drugs active in the tumor microenvironment, an important component of tumor biology where tumors interact with non-malignant tissue and can dramatically affect drug sensitivity.

Ann Arbor, Michigan

Strategy and Market Development

Ann Arbor, MI

Active board member and member of the Executive Management Team with NeuroNexus Technologies, a leading edge commercial phase neural stimulation and recording company.http://www.neuronexus.com

Ann Arbor, Michigan

Strategic and Financial Planning.

Lansing, Michigan

nanoRETE, Inc. was an early stage Michigan-based company that was developing technologies to provide real-time detection of pathogens and toxins using customized, proprietary nanoparticle biosensors.

Battle Creek, MI

As part of the Global Food Protection Institues the ETA provides entrepreneurial support to fast track the development of emerging technologies that could safeguard public health.

Rubicon Genomics is a commercial phase nucleic acid amplification platform and molecular diagnostic company serving the life sciences and medical industries.

Ann Arbor, Michigan

Strategic Consulting, including business plan, sales strategy development, and exit plan for an early stage neural device company.

Independent consultant to pharmaceutical, fine chemical and biotechnology industries covering market development, license and cross licensing, and M & A.

Three billion dollar specialty chemical company that purchased NSC Technologies. I was responsible for the integration of NSC Technologies with focus on sales, marketing, and business development for pharmaceutical intermediates on a global basis.

A Monsanto funded startup company, which developed & produced pharmaceutical intermediates for the pharma outsource marketplace utilizing the combination of biotech and organic chemistry technology bases. Company Sold to Great Lakes Chemical Company.

Privately financed company in the specialty urethane, thermoplastic urethane and thermoplastic elastomer industry.

Venture capital backed specialty lubricants and coating company selling formulated products and application equipment into the industrial and retail markets. Exited through sale.

A Division of Hexcel involved in fine chemical and advanced materials with operations in the United States, France, United Kingdom, Germany and Spain.

Mba, Finance And Economics

Distinguished Achievements in Economic Analysis and Managerial Analysis

Bs, Industrial Relations/Economics